[14C]-(3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [14C]-(3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one, covering 2025-04-27 to 2025-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one [NA]